New oral antiviral drug to be used for treatment of COVID-19
By Zhang Zhihao |
chinadaily.com.cn |
Updated: 2023-03-23 19:18
Share
Share - WeChat
The National Medical Products Administration has recently granted conditional market approval for an oral antiviral drug RAY1216 in a bid to treat COVID-19.
The drug can be used to treat adults with mild and moderate symptoms of COVID-19, but it must be taken under medical supervision, the administration said.
RAY1216 is a drug developed by Guangdong Zhongsheng Pharmaceutical.
- Report on Shenzhen-Jiangmen railway collapse documents regulation violations
- GX Foundation opens its global headquarters in Hong Kong
- China's success in development empowers Global South
- Study explains why Chang'e 6 moon soil is unexpectedly sticky
- Rare Sapria himalayana once again enters blooming period in Yunnan
- Shenzhou XXII to launch with full cargo load
